|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Clinic for Anesthesiology, University of Ulm, Ulm, Germany
2 Clinic for Anesthesiology, University of Ulm, Ulm, Germany; Ulm, Germany
* To whom correspondence should be addressed. E-mail: karl.foehr{at}uniklinik-ulm.de.
Previous studies had not excluded the possibility that the mechanism by which Xenon (Xe) blocks N-methyl-D-aspartate (NMDA) receptors might be that of an open-channel blocker. We tested this possibility on mutant NMDA receptors carrying an alanine (A) to cysteine (C) mutation located within the SYTANLAAF-motif of the third transmembrane region (TM3). This mutation was shown to yield constitutively open ion channels after modification with a thiol-modifying reagent. We expressed such mutant channels in Neuro2A cells and recorded glutamate (50 µM)-induced currents in the whole-cell recording mode. While Xe (3.5 mM) blocked the currents through the wild-type receptor NR1-1a/NR2A and NR1-1a/NR2B by about 40% and those through the mutant receptors NR1-1a/NR2A(A650C) or NR1-1a/NR2B(A651C) by about 30%, it was unable to block the currents through the methane thiosulfonate etyhlammonium (MTSEA)-modified mutant receptors. On the other hand, established open-channel blockers of the NMDA receptor such as MK-801 (1 µM) or Mg ions (Mg2+; 1 mM) were able to block these permanently open channels. These results suggest that Xe does not act as a classical open-channel blocker at the NMDA receptor.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |